Andrew specializes in commercial health insurance pricing and pharmaceutical consulting. His areas of expertise include benefits pricing, reserving, financial forecasting, claims analysis, and model development.
Andrew primarily assists clients with individual and small group market federal and state filings of premium rates under the Affordable Care Act.
Andrew has also consulted on various alternative payment risk-sharing strategies for pharmaceutical clients and assisted clients in the analysis of healthcare utilization, costs, and trends using large commercial, Medicare, and Medicaid claims databases.
Prior to joining Milliman, Andrew worked for a large consulting firm where he performed valuations for defined benefit pension plans, consulted on de-risking strategies for pension plans, and performed asset-liability studies to determine the optimal level of risk that pension plans should incorporate in their investments.
